Singapore: Israel-based Can-Fite BioPharma announced that the active pharmaceuticals ingredients (API) of CF101 and CF102 are up-scaled and manufactured by Chemspec, a leading Chinese CRO.

This will support the on-going advanced stage clinical trials conducted by the company with a more efficient and less costly procedure. It will also enable the company to supply API to its current and future strategic partners.